
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic expos... Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0298 | 6.08163265306 | 0.49 | 0.6099 | 0.49 | 1850000 | 0.54218606 | CS |
4 | -0.0714 | -12.0771312585 | 0.5912 | 0.6978 | 0.43305 | 2524552 | 0.54249489 | CS |
12 | -0.4302 | -45.2842105263 | 0.95 | 0.9901 | 0.43305 | 4386710 | 0.69010712 | CS |
26 | -4.4202 | -89.4777327935 | 4.94 | 10.6237 | 0.43305 | 5057151 | 3.20022912 | CS |
52 | -4.8502 | -90.3202979516 | 5.37 | 10.6237 | 0.43305 | 2976454 | 3.54804288 | CS |
156 | -1.0502 | -66.8917197452 | 1.57 | 10.6237 | 0.43305 | 1439153 | 3.30023188 | CS |
260 | -24.2102 | -97.8980994743 | 24.73 | 51.99 | 0.43305 | 927119 | 4.5305684 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales